313: Biotech layoffs, founder-focused VC, & a big pharma exit
The Readout Loud
Analysis of Pfizer's R&D Chief Departure and Its Implications for the Company
Debate over the implications of Pfizer's R&D chief leaving after 15 years, questioning the impact on the company's performance in a post-COVID world and its ability to address challenges in pipeline strength and growth strategies.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
